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Abstract We have previously shown that the EGFR kinase 
selective tyrphostin AG 494 fails to inhibit EGFR kinase in 
intact cells. Yet, AG 494 proved to inhibit EGF- or serum-
induced cell proliferation (Osherov et al., J. Biol. Chem. 268 
(1993) 11134-11142). In this preliminary communication we 
show that AG 494 as well as its close analogs AG 490 and 
AG 555 block Cdk2 activation. In contrast, AG 1478, a more 
selective EGFR kinase blocker which is also active as EGFR 
kinase blocker in intact cells, fails to do so. AG 494 exerts its full 
inhibitory activity on Cdk2 activation even when added 20 h 
subsequent to EGF addition when Cdk2 activation is maximal. 
The inhibitory activity on Cdk2 activation parallels its DNA 
synthesis inhibitory activity, strongly suggesting that its target is 
one of the molecular mechanisms involved in Cdk2 activation. 
AG 494 and its analogs may become useful lead compounds for 
the development of drugs aimed at the cell cycle machinery. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
We have recently developed a group protein tyrosine kinase 
(PTK) inhibitors (tyrphostins) represented by A G 494, capa-
ble of selectively inhibiting the E G F receptor (EGFR) kinase 
activity in the cell-free kinase assay. This compound and its 
close analogs were found to poorly inhibit other protein ty-
rosine kinases, even the closely related H E R - 2 kinase [1,2]. 
Surprisingly, these compounds had no effect on tyrosine phos-
phorylation in intact cells but nevertheless were found to ex-
hibit potent antimitogenic activity. 
We were able to show that these inhibitors are competitive 
with A T P and that the loss of inhibition of the E G F receptor 
kinase activity in the intact cells is due to high intracellular 
levels of ATP, which prevents inhibitor binding to the kinase 
site of the receptor [2]. Since the anti-mitogenic activity of 
A G 494 is independent of the high A T P concentration, we 
decided to explore in more detail its mode of action. 
In this study, we have analyzed the mode of anti-mitogenic 
action of A G 494 in intact cells, as compared to A G 1478, a 
potent E G F R tyrosine kinase inhibitor which is active in cell-
free as well as intact cells [3,4]. We show that A G 494 in 
contrast to A G 1478, inhibits signaling downstream of the 
E G F R and blocks Cdk2 activation. 
2. Material and methods 
2.1. Synthetic methods 
The synthesis of AG 494 and AG 1478 is described elsewhere [1,4]. 
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2.2. Cell culture 
Cells termed DHER-14 were prepared by transfecting NIH-3T3 
cells (clone 2.2) which lack endogenous EGF receptors with wild-
type HER-1/EGF receptor and is the same used in our previous study 
[2]. The cell line was a generous gift of Drs. Asher Zilberstein, Joseph 
Schlessinger and Axel Ullrich. Cells were grown in DMEM supple-
mented with 10% calf serum (Gibco). 
2.3. Preparation of crude membrane extract 
Cells were lysed in hypotonic lysis buffer (1 X 106 cells/ml lysis buf-
fer) containing 20 mM HEPES (pH 7.4), 10 mM NaCl, 2 mM EDTA, 
1 mM PMSF, 10 |J,g/ml aprotinin, 5 |J,g/ml leupeptin, and homogen-
ized in a tight-fit homogenizer. Nuclei and debris were pelleted at 
600 Xg for 10 min, and discarded. The supernatant was centrifuged 
at lOOOOOXg for 30 min and the resulting crude membrane pellet was 
resuspended in 125 mM NaCl, 50 mM HEPES (pH 7.4), 10% glycerol 
and frozen in liquid nitrogen. 
2.4. Inhibition of autophosphorylation 
Membranes (2 |ig/assay) were pre-incubated with EGF (50 nM) in 
50 mM HEPES (pH 7.4), 125 mM NaCl, for 15 min at 4°C. The assay 
was initiated by addition of 8 ul membranes to 12 [i\ reaction mixture 
containing 50 mM HEPES (pH 7.4), 125 mM NaCl, 2 u.M ATP 
(=2 Kla final), 1 uCi [
32P]y-ATP, 4 mM MnCl2, 24 mM MgCl2, 
and 4 ul tyrphostin dissolved in 10% Me2 SO/45% ethanol/45% 
DDW (double-distilled water). The assay was conducted at 4°C and 
terminated after 30 s by the addition of 8 ul boiling SDS-PAGE 
sample buffer. Proteins were separated on 6% SDS-PAGE, and auto-
radiography performed. A single EGF inducible 32P-labeled band 
comigrating in the molecular weight of the receptor could then be 
detected. This band was scanned and quantified by densitometry 
(Zeineh soft laser, Biomed). IC50 values were calculated using the E-
Z fit program (Perrella, Du-Pont). 
All reactions were performed rapidly in V-shaped 96-well plates 
using a multipipette. Reactions were all linear for 30 s. The exposure 
times of the autoradiograms were controlled so that film exposure was 
linear. Basal EGF-independent activity did not exceed 5% of the EGF-
activated autophosphorylation of HER-1/EGF receptors. Inhibition 
of pp60c~src activity was essentially performed as described by using 
the DHER-14 cells as described in detail previously, using denatured 
enolase as a substrate [3]. Inhibition of autophosphorylation of wheat-
germ agglutinin (WGA) purified insulin-receptor was performed as 
described by Schechter et al. [6]. Inhibition of autophosphorylation 
of HER-2/Neu receptor was performed using membranes prepared 
from NIH-3T3 cells using published procedures [1,2] transfected 
with the human HER-2/Neu receptor as described for HER-1 [1]. 
2.5. Inhibition of [3H]thymidine uptake 
Cells were seeded at 7000 cells/well in 96-well Costar dishes pre-
coated with 1 (ig/well human fibronectin (Boehringer-Mannheim). The 
cells were grown to confluence for 2 days. The medium was changed 
to DMEM containing 0.25%> calf serum for 48 h and the cells were 
then incubated 16 h with either 20 nM EGF (Serotec), 50 uM lyso-
phosphatidic acid or 50 ng/ml TPA (phorbol ester). After 16 h, 
[3H]thymidine 0.5 uCi/ml was added for 4 h. Different concentrations 
of tyrphostins dissolved at X 100 concentration in 10% Me2SO were 
added either 30 min prior to the addition of mitogens, or during the 
last 4 h along with [3H]thymidine addition. The trichloroacetic acid-
precipitable material was quantified by scintillation counting. Basal 
EGF-independent activity did not exceed 5% of mitogen-dependent 
[3H]thymidine uptake activity of DHER-14 cells. Tyrphostins were 
added either 30 min prior to EGF addition or at the time of 
[3H]thymidine addition. Thus AG 494 and AG 1478 were present 
either for 20 or 4 h. 
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2.6. Immunoprecipitation and immunoblot analysis 
Cells were plated at 2X105 cells/5 ml/well in Costar 6-well dishes, 
grown to confluence for 2 days and then starved in 2 ml/well DMEM 
containing 0.25% calf serum for 48 h. Tyrphostins dissolved at X 100 
concentration in 10% Me2SO were added during the last 16 h or the 
last 2 h of starvation. EGF (20 nM) was then added and the plates 
were incubated for 2 min at 4°C with EGF (20 nM), during which 
time receptor autophosphorylation is linear [7]. The reaction was ter-
minated by addition of 1 ml/well stop lysis buffer containing 20 mM 
HEPES (pH 7.4), 125 mM NaCl, 1% Triton X-100, 5 mM NaF, 100 
uM NaVOs, 200 uM ZnCl2, 1 mM EDTA, 2 mM EGTA, 1 mM 
PMSF, 10 |Xg/ml aprotinin, 5 u,g/ml leupeptin. Immunoprecipitation 
using monoclonal antibody 108 was performed as described above. 
The immunocomplex was released in boiling sample buffer, and then 
samples were run on SDS-PAGE 5-15% gradient gels, transferred to 
nitrocellulose (ABN semi-dry blot), blocked for 30 min in TBST (Tris 
buffer saline (pH 7.4), 1% Tween-20, 5% bovine serum albumin), then 
probed with monoclonal anti-phosphotyrosine antibodies PT66 (Sig-
ma-Biomakor) for 3 h at 40°C in TBST, washed 4 times in TBS, and 
then reproved with [125I]goat anti-mouse antibodies (1 |j,Ci/ml). The 
blots were then washed 4 times in TBS, air dried and analyzed by 
autoradiography. 
2.7. Immunoprecipitation and Cdk2 kinase assays 
DHER-14 cells were grown to confluence for 48 h in Costar 6-well 
dishes in DMEM +10% calf serum as described. Cells were starved for 
3 days. During the last 24 h, cells were activated by various mitogens 
(20 nM EGF; 50 ng/ml TPA phorbol ester) or 50 uM lysophospha-
tidic acid (LPA) for various time periods. Cells were incubated with 
tyrphostins as described for each experiment. Cells were washed once 
in PBS, then lysed on ice using 1 ml/well cold IP buffer (50 mM 
HEPES, 250 mM NaCl, 5 mM DTT, 0.25% NP-40, 10 mM NaF, 
and protease inhibitors). Lysates were incubated on ice for 30 min, 
then centrifuged 14000Xg for 15 min in a microfuge. Supernatants 
were transferred, and incubated for 2 h in the presence of a saturating 
concentration of 1 ug/eppendorf anti-Cdk2 antibodies. The immuno-
complex was collected on protein A agarose beads (7.5 ill packed 
volume per eppendorf) and washed 3 times in IP buffer. The pellet 
was then washed a fourth time in kinase buffer (50 mM HEPES, 10 
mM MgCl, 1 mM DTT, 1 uM cold ATP). All buffer was aspirated 
from the beads with a fine bore Hamilton syringe, and the kinase 
reaction initiated by the addition of 40 ul/eppendorf reaction mixture 
containing kinase buffer and 1 (iCi/assay [y-32P]ATP and 2.5 ug His-
tone HI (freshly prepared) per assay. 
The reaction was performed for 20 min at 30°C, then stopped by 
addition of 12.5 |xl/assay SDS-PAGE sample buffer X4. Samples were 
separated on 10% SDS PAGE gels and exposed to film for ~ 2 h at 
—70°C. Quantitation was performed by densitometry. 
3. Results 
The tyrphostin AG 494 and the quinazoline AG 1478 have 
been shown to selectively inhibit EGF receptor tyrosine kinase 
activity in vitro as compared to a variety of tyrosine kinases, 
including the closely related HER-2/Neu receptor (Table 1) 
[1-4]. 
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Fig. 1. Inhibition of EGF-induced [3H]thymidine uptake by 
AG 1478 and AG 494. DHER-14 cells were serum starved for 48 h 
at 0.25% serum. Then EGF (20 ug/ml) was added for 20 h. 
[3H]Thymidine was added after 16 h and tyrphostins were added ei-
ther just prior to EGF addition or at 16 h. Other details are given 
in Section 2. 100% activity is 98000 dpm. 
We have previously shown that AG 494 does not inhibit 
EGF receptor autophosphorylation and phosphorylation of 
endogenous substrates in intact DHER-14 cells [2]. In con-
trast, AG 1478, inhibits this activity effectively at doses sim-
ilar to those shown to inhibit receptor activity in vitro [3,4]. 
3.1. Inhibition of EGF-dependent DNA synthesis 
Growth-arrested DHER-14 cells were activated with EGF, 
TPA and LPA, and the extent of DNA synthesis measured by 
[3H]thymidine uptake. AG 494 inhibits 50% of TPA- and 
LPA-dependent [3H]thymidine uptake at = 5 uM, whereas 
EGF-dependent [3H]thymidine uptake is inhibited at ~ 10.5 
u,M (Figs. 1 and 2). In contrast, and as expected for the more 
selective EGF receptor inhibitor, AG 1478, inhibits 50% of 
the EGF-dependent [3H]thymidine uptake at ~0 .3 uM, 
whereas LPA- and TPA-dependent [3H]thymidine uptake are 
inhibited at ~ 8-fold higher concentrations (Figs. 1 and 2). 
Table 1 
Inhibition of autophosphorylation of various tyrosine kinases by AG 1478 and AG 494 
Tyrosine kinase Preparation 
M s ° ~ T ^ Y ^ f N Cl 
H O fY> J l N 
HO-KJ CN H 
AG 1478 IC50 (|iM) AG 494 IC50 (uM) 
EGFR/HER-1 
HER-2/neu 
Insulin-R 
c-src 
membranes 
membranes 
WGA-purif. 
immunoppt 
0.0020 
2.6 
> 100 
>100 
1.1 ±0.24 
39 ±13 
>100 
>100 
Experimental details on the methodology for the determination of the IC50 are given in Section 2. 
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Fig. 2. Inhibition of [3H]thymidine uptake induced by EGF, TPA 
and LPA by AG 1478 and AG 494. 100% is 96000 dpm for EGF, 
85000 with TPA and 88000 with LPA. 10% serum under identical 
conditions yields 138000 dpm. 
These results imply that AG 494 exerts its antimitogenic ef-
fects by inhibiting a signal transduction element acting down-
stream of the EGF receptor and which is common to EGF, 
TPA, LPA (Fig. 2) and serum [2]. 
AG 494 inhibits EGF-dependent [3H]thymidine uptake 
with equal potency when added either just prior to EGF acti-
vation, or 16 h later, upon [3H]thymidine addition when the 
cells are mostly in late Gl/early S (Fig. 1). In contrast, 
AG 1478, as expected for a more selective EGFR kinase in-
hibitor, inhibits EGF-dependent [3H]thymidine uptake far 
more potently when added just prior to EGF activation 
(Fig. 1). This result further supports the notion that AG 494 
exerts its antimitogenic effect by inhibiting a signal transduc-
tion element downstream of the EGFR. Since we found that 
AG 494 does not inhibit directly MAPK ([8], data not shown) 
or the DNA replication machinery as measured on isolated 
drosophila nuclei ([8], data not shown), we hypothesized that 
AG 494 may block the cell cycle machinery governing Gl to S 
transition. Another reason for testing the cell cycle machinery 
was because AG 494 inhibits mitogenesis induced by EGF 
also by other mitogens such as TPA and LPA (Fig. 1) as 
well as serum [2]. Because AG 494 was found to block 
DNA synthesis even at 16 h after stimulation (Fig. 1) we 
decided to focus on Cdk2. 
3.2. EGF-dependent activation of Cdk.2 kinase in DHER-14 
cells 
Growth-arrested DHER-14 cells were stimulated by EGF 
for various time periods, and Cdk2 kinase activity was meas-
ured by histone HI phosphorylation (Fig. 3A). Maximal stim-
ulation was attained after 24 h of stimulation and decreased 
within the next 24 h (48 h total incubation time). Activation 
was completely abolished by preblocking the antibodies with 
the cognate peptide (not shown). TPA and LPA stimulation 
followed a very similar time course of activation (not shown). 
3.3. Inhibition of Cdk2 activation in DHER-14 cells by 
tyrphostins 
Tyrphostins of the AG 494 group were added during the 
last 4 h of stimulation by EGF. AG 494, AG 490, AG 555 at 
a concentration of 30 uM, ~2.5-fold the IC50 for thymidine 
uptake inhibition (Fig. 1) inhibit > 80% of Cdk2 activity (Fig. 
3A). AG 1478 at a concentration of 2 uM, ~ 7.5-fold concen-
tration of that of IC50 for thymidine uptake inhibition (Fig. 1) 
has only a small effect (Fig. 3B). 
AG 494 inhibits in a dose-dependent manner of Cdk2 
EGF-dependent activation with an IC50 ~ 15 uM (Fig. 3B) 
very similar to the IC50 value required to inhibit thymidine 
uptake (10.3-12 uM; Figs. 1 and 2). AG 1478 was only 
slightly inhibitory and induced only 31% at 2 (J.M when added 
at 20-24 h (Fig. 3B) similar to its DNA inhibitory effect when 
added late (Fig. 1). These results also support the more selec-
tive nature of AG 1478 whose inhibitory activity is most ef-
fective when added early upon EGF stimulation (Fig. 1). 
Maximal inhibition of Cdk2 activity is attained after 4 h of 
incubation of cells with 30 uM AG 494 where incubation of 
less than 1 h was markedly less effective (Fig. 3C). Since the 
kinetics of AG 494 cell entry has a half-life of ~ 10 min [2,8], 
it seems that the onset of the process of inhibition of Cdk2 
activation has a half-life of ~ 1 h. 
4. Discussion 
Over the past decade a large number of PTK inhibitors 
have been synthesized, among them the tyrphostins [9]. 
Although, some tyrphostins like AG 494 were shown to be 
selective against EGFR kinase in cell-free assay they failed 
to retain this property in intact cells [2]. Yet, in spite of the 
failure of AG 494 to retain its EGFR kinase inhibitory activ-
ity in intact cells, it retained its anti-proliferative activity [2] 
(Figs. 1 and 2). It was found that AG 494 retains its full 
inhibitory activity on EGF-dependent DNA synthesis meas-
ured by [3H]thymidine uptake, even when added 20 h subse-
quent to EGF addition (Fig. 1). Since AG 494 inhibits not 
only EGF- but also serum-dependent cell growth [2] and 
LPA- or TPA-dependent DNA synthesis (Fig. 2) it is ap-
parent that the target of AG 494 action in intact cells is down-
stream to the EGFR kinase, as compared to the more selec-
tive EGFR kinase inhibitor AG 1478 which is also active as a 
selective EGFR kinase inhibitor in intact cells [3,8]. In this 
study we show that AG 494 and its analogs AG 490 and 
AG 555 block the activation of Cdk2 (Fig. 3B), a property 
not shared by AG 1478 (Fig. 3C). Activation of Cdk2 de-
pends on a number of molecular events such as binding of 
cyclins, the dephosphorylation of the Thr14 and Tyr15 as well 
as the activating phosphorylation of Thr161 [10]. Our results 
also do not rule out an effect of AG 494 on Cdk 4 which is 
activated in early Gl [10]. These and other molecular param-
eters are currently under investigation. Upon the hopeful 
identification of the molecular target(s) for AG 494 and its 
analogs it will be possible to design more potent inhibitors 
targeted to the inhibition of Cdk2 activation. Hopefully, iden-
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Fig. 3. Cdk2 activation and its inhibition by tyrphostins. Growth-arrested DHER-14 cells were activated by EGF (20 ng/ml). At various time 
points Cdk2 was immunoprecipitated and its activity using HI histone was measured. Tyrphostins were added between 20-24 h. Other details 
are given in Section 2. A: Kinetics of Cdk2 activation and its inhibition by members of AG 494. B: Dose-dependent inhibition of Cdk2 activa-
tion by AG 494 and AG 1478. Bottom: a typical HI phosphorylation assay and its inhibition. C: Kinetics of onset of Cdk2 kinase inhibition. 
As indicated AG 494 was added 20 h subsequent to EGF addition. Samples were removed, Cdk2 immunoprecipitated and its activity measured. 
tification of such a target may also help in designing agents 
which block Cdk4 activation. Such inhibitors have the poten-
tial to become useful anti-proliferative agents. 
References 
[1] Gazit, A., Osherov, N., Posner, I., Yaish, P., Poradosu, E., Gi-
lon, C. and Levitzki, A. (1991) J. Med. Chem. 34, 1896-1907. 
[2] Osherov, N., Gazit, A., Gilon, C. and Levitzki, A. (1993) J. Biol. 
Chem. 268, 11134-11142. 
[3] Osherov, N. and Levitzki, A. (1994) Eur. J. Biochem. 226, 1-13. 
[4] Gazit, A., Chen, J., App, H., McMahon, G., Hirth, P., Chen, I. 
and Levitzki, A. (1996) Biorg. Med. Chem. 8, 1203-1207. 
[6] Shechter, Y., Yaish, P., Chorev, M., Gilon, C , Braun, S. and 
Levitzki, A. (1989) EMBO J. 8, 1671-1676. 
[7] Yaish, P., Gazit, A., Gilon, C. and Levitzki, A. (1988) Science 
242, 933-935. 
[8] N. Osherov, Ph.D. Thesis, The Hebrew University of Jerusalem, 
1994. 
[9] Levitzki, A. and Gazit, A. (1995) Science 267, 1782-1788. 
[10] Elledge, S.J. (1997) Science 274, 1664-1672. 
